Skip to Content

Antibodies, Volume 11, Issue 1

2022 March - 21 articles

Cover Story: Dendritic cells (DCs) take up, process, and present foreign and self-antigens to T cells, resulting in critical interactions that initiate and regulate specific immune responses. Recombinant immunoglobulins, derived from monoclonal antibodies recognizing the defined surface epitopes expressed on functionally distinct subsets of DCs, have been utilized for the past two decades to deliver antigens to DCs in vivo, serving as critical tools for the investigation of corresponding T cell responses. These antigen-delivery methodologies helped to reveal the mechanisms underlying tolerogenic and immunogenic T cell responses orchestrated by DCs and may be employed for the treatment of various diseases, including cancer and autoimmunity. View this paper.
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (21)

  • Article
  • Open Access
6 Citations
5,777 Views
14 Pages

Highly Specific Monoclonal Antibody Targeting the Botulinum Neurotoxin Type E Exposed SNAP-25 Neoepitope

  • Adva Mechaly,
  • Eran Diamant,
  • Ron Alcalay,
  • Alon Ben David,
  • Eyal Dor,
  • Amram Torgeman,
  • Ada Barnea,
  • Meni Girshengorn,
  • Lilach Levin and
  • Ohad Mazor
  • + 4 authors

16 March 2022

Botulinum neurotoxin type E (BoNT/E), the fastest acting toxin of all BoNTs, cleaves the 25 kDa synaptosomal-associated protein (SNAP-25) in motor neurons, leading to flaccid paralysis. The specific detection and quantification of the BoNT/E-cleaved...

  • Article
  • Open Access
13 Citations
4,593 Views
15 Pages

Reactivity of Rheumatoid Arthritis-Associated Citrulline-Dependent Antibodies to Epstein-Barr Virus Nuclear Antigen1-3

  • Ilaria Fanelli,
  • Paolo Rovero,
  • Paul Robert Hansen,
  • Jette Lautrup Frederiksen,
  • Gunnar Houen and
  • Nicole Hartwig Trier

11 March 2022

Rheumatoid arthritis (RA) is a chronic disease which causes joint inflammation and, ultimately, erosion of the underlying bone. Diagnosis of RA is based on the presence of biomarkers, such as anti-citrullinated protein antibodies (ACPA) and rheumatoi...

  • Article
  • Open Access
7 Citations
7,265 Views
10 Pages

Design and Characterization of Novel Antibody-Cytokine Fusion Proteins Based on Interleukin-21

  • Cesare Di Nitto,
  • Dario Neri,
  • Tobias Weiss,
  • Michael Weller and
  • Roberto De Luca

Interleukin-21 (IL21) is a pleiotropic cytokine involved in the modulation of both innate and adaptive immunity. IL21 is mainly secreted by natural killer (NK) and activated CD4+ T-cells. The biology of this cytokine can be associated to proinflammat...

  • Article
  • Open Access
5 Citations
4,672 Views
43 Pages

Serum anti-HLA-I IgG are present in non-alloimmunized males, cancer patients, and transplant recipients. Anti-HLA-I antibodies are also present in intravenous immunoglobulin (IVIg), prepared from the plasma of thousands of healthy donors. However, th...

  • Review
  • Open Access
55 Citations
22,469 Views
41 Pages

25 February 2022

Identification of new disease-associated biomarkers; specific targeting of such markers by monoclonal antibodies (mAbs); and application of advances in recombinant technology, including the production of humanized and fully human antibodies, has enab...

  • Review
  • Open Access
13 Citations
9,557 Views
14 Pages

21 February 2022

Bispecific antibodies (bsAbs) are molecules that simultaneously bind two different antigens (Ags). bsAbs represent a very active field in tumor immunotherapy with more than one hundred molecules currently being tested. More specifically, they have el...

  • Article
  • Open Access
5 Citations
5,177 Views
19 Pages

16 February 2022

This study aimed to investigate PD-L1 and PD-1 expression in circulating CD20+ cells in diffuse larger B-cell lymphoma (DLBCL) and to evaluate the predictive and diagnostic performance of PD-L1 versus PD-1 expression in circulating CD20+ cells in DLB...

  • Communication
  • Open Access
5 Citations
5,862 Views
9 Pages

More Than Meets the Kappa for Antibody Superantigen Protein L (PpL)

  • Wei-Li Ling,
  • Joshua Yi Yeo,
  • Yuen-Ling Ng,
  • Anil Wipat and
  • Samuel Ken-En Gan

11 February 2022

Immunoglobulin superantigens play an important role in affinity purification of antibodies and the microbiota-immune axis at mucosal areas. Based on current understanding, Staphylococcal Protein A (SpA), Streptococcal Protein G (SpG) and Finegoldia P...

  • Article
  • Open Access
12 Citations
6,120 Views
13 Pages

Anti-SARS-CoV-2 Omicron Antibodies Isolated from a SARS-CoV-2 Delta Semi-Immune Phage Display Library

  • Ivette Mendoza-Salazar,
  • Keyla M. Gómez-Castellano,
  • Edith González-González,
  • Ramsés Gamboa-Suasnavart,
  • Stefany D. Rodríguez-Luna,
  • Giovanni Santiago-Casas,
  • María I. Cortés-Paniagua,
  • Sonia M. Pérez-Tapia and
  • Juan C. Almagro

10 February 2022

This report describes the discovery and characterization of antibodies with potential broad SARS-CoV-2 neutralization profiles. The antibodies were obtained from a phage display library built with the VH repertoire of a convalescent COVID-19 patient...

  • Article
  • Open Access
12 Citations
10,276 Views
22 Pages

Cryopreservation of Natural Killer Cells Pre-Complexed with Innate Cell Engagers

  • Uwe Reusch,
  • Kristina Ellwanger,
  • Ivica Fucek,
  • Thomas Müller,
  • Ute Schniegler-Mattox,
  • Joachim Koch and
  • Michael Tesar

9 February 2022

Innate cell engager (ICE®) constructs are bispecific tetravalent antibodies targeting specific tumor antigens and simultaneously engaging natural killer (NK) cell and macrophage receptors for the destruction of tumor cells. Pre-complexing of ICE&...

  • Article
  • Open Access
5 Citations
4,402 Views
18 Pages

Functional Changes of Therapeutic Antibodies upon Exposure to Pro-Oxidative Agents

  • Maxime Lecerf,
  • Robin Lacombe,
  • Alexia Kanyavuz and
  • Jordan D. Dimitrov

2 February 2022

Therapeutic monoclonal antibodies have exerted a transformative impact on clinical practice in last two decades. However, development of a therapeutic antibody remains a complex process. Various physiochemical and functional liabilities can compromis...

  • Article
  • Open Access
28 Citations
14,202 Views
18 Pages

Construction of a Humanized Artificial VHH Library Reproducing Structural Features of Camelid VHHs for Therapeutics

  • Taihei Murakami,
  • Shigefumi Kumachi,
  • Yasuhiro Matsunaga,
  • Miwa Sato,
  • Kanako Wakabayashi-Nakao,
  • Hidekazu Masaki,
  • Ryo Yonehara,
  • Maiko Motohashi,
  • Naoto Nemoto and
  • Masayuki Tsuchiya

30 January 2022

A variable domain of heavy chain antibody (VHH) has different binding properties than conventional antibodies. Conventional antibodies prefer binding to the convex portion of the antigen, whereas VHHs prefer epitopes, such as crevices and clefts on t...

  • Review
  • Open Access
10 Citations
9,981 Views
14 Pages

25 January 2022

Recombinant immunoglobulins, derived from monoclonal antibodies recognizing the defined surface epitopes expressed on dendritic cells, have been employed for the past two decades to deliver antigens to dendritic cells in vivo, serving as critical too...

  • Review
  • Open Access
25 Citations
6,562 Views
13 Pages

21 January 2022

Antibodies against platelet factor 4 (PF4), a protein released from alpha-granules of activated platelets, may cause a number of pathophysiological conditions. The most commonly known is heparin-induced thrombocytopenia (HIT), which develops in a sma...

  • Article
  • Open Access
13 Citations
7,971 Views
14 Pages

Engineering an Enhanced EGFR Engager: Humanization of Cetuximab for Improved Developability

  • Dennis R. Goulet,
  • Soumili Chatterjee,
  • Wai-Ping Lee,
  • Andrew B. Waight,
  • Yi Zhu and
  • Amanda Nga-Sze Mak

13 January 2022

The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase whose proliferative effects can contribute to the development of many types of solid tumors when overexpressed. For this reason, EGFR inhibitors such as cetuximab can play an i...

  • Review
  • Open Access
12 Citations
11,299 Views
13 Pages

New Opportunities in Glycan Engineering for Therapeutic Proteins

  • Xiaotian Zhong,
  • Aaron M. D’Antona,
  • John J. Scarcelli and
  • Jason C. Rouse

10 January 2022

Glycans as sugar polymers are important metabolic, structural, and physiological regulators for cellular and biological functions. They are often classified as critical quality attributes to antibodies and recombinant fusion proteins, given their imp...

  • Article
  • Open Access
7 Citations
4,417 Views
16 Pages

TCDD Inhibition of IgG1 Production in Experimental Autoimmune Encephalomyelitis (EAE) and In Vitro

  • Ashleigh J. Nicaise,
  • Amye McDonald,
  • Erin Rushing Sears,
  • Trell Sturgis and
  • Barbara L. F. Kaplan

9 January 2022

The environmental contaminant 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD) is a ligand for the aryl hydrocarbon receptor (AhR). TCDD is well-characterized to produce immunotoxicity, including suppression of antibody production. Previously we showed...

  • Communication
  • Open Access
2 Citations
4,325 Views
9 Pages

Immune Maturation Effects on Viral Neutralization and Avidity of Hyperimmunized Equine Anti-SARS-CoV-2 Sera

  • Myriam Belén González Viacava,
  • Augusto Varese,
  • Ignacio Mazzitelli,
  • Laura Lanari,
  • Lucía Ávila,
  • María Julia García Vampa,
  • Jorge Geffner,
  • Osvaldo Cascone,
  • José Christian Dokmetjian and
  • Matías Fingermann
  • + 1 author

2 January 2022

Mass-vaccination against COVID-19 is still a distant goal for most low-to-middle income countries. The experience gained through decades producing polyclonal immunotherapeutics (such as antivenoms) in many of those countries is being redirected to de...

  • Article
  • Open Access
12 Citations
7,567 Views
16 Pages

28 December 2021

Bispecific antibodies (BsAb) that engage multiple pathways are a promising therapeutic strategy to improve and prolong the efficacy of biologics in complex diseases. In the early stages of discovery, BsAbs often exhibit a broad range of pharmacokinet...

  • Review
  • Open Access
14 Citations
8,448 Views
21 Pages

21 December 2021

Peptides are short chains of 2 to 50 amino acids (molecular weight of less than 10 kDa) linked together by peptide bonds. As therapeutic agents, peptides are of interest because the body naturally produces many different peptides. Short-chain peptide...

XFacebookLinkedIn
Antibodies - ISSN 2073-4468